What is Immunome's total current assets?

Immunome (IMNM) reported total current assets of $594.31M in Q1 2026.

How has Immunome's total current assets changed year-over-year?

Immunome's total current assets increased by 83.9% year-over-year, from $323.13M to $594.31M.

What is the long-term trend for Immunome's total current assets?

Over 5 years (2020 to 2025), Immunome's total current assets has grown at a 72.8% compound annual growth rate (CAGR), from $42.89M to $660.78M.

What does total current assets mean?

The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Immunome IMNM Total Current Assets

Total Current Assets at other companies

PfizerPFE

$42.82B-6.6%

Arcus BiosciencesRCUS

$844M-18.1%

Nuvation BioNUVB

$591.53M+24.4%

SELLAS Life Sciences Group, Inc.SLS

$111.17M+248%

ArriVent BioPharma, Inc.AVBP

$348.7M+87.7%

IDEAYA Biosciences, Inc.IDYA

$696.11M-1.7%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's total current assets?: Immunome (IMNM) reported total current assets of $594.31M in Q1 2026.
How has Immunome's total current assets changed year-over-year?: Immunome's total current assets increased by 83.9% year-over-year, from $323.13M to $594.31M.
What is the long-term trend for Immunome's total current assets?: Over 5 years (2020 to 2025), Immunome's total current assets has grown at a 72.8% compound annual growth rate (CAGR), from $42.89M to $660.78M.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.